Literature DB >> 2417308

HLA control of the proliferative T lymphocyte response to antigenic determinants on mumps virus. Studies of healthy individuals and patients with type 1 diabetes.

O Bruserud, E Thorsby.   

Abstract

The proliferative T lymphocyte responses to two different mumps antigen preparations, S (nucleocapsid) and V (viral envelope), were characterized. Eight patients with Type 1 (insulin-dependent) diabetes mellitus were all found to be responders to S and V mumps antigen. Among the 64 healthy individuals, 52 were classified as responders to the S antigen and 50 responders to the V antigen. No difference was found between T lymphocytes from Type 1 diabetic patients and those from healthy individuals as regards the effect of indomethacin on the mumps-specific response. The majority of the mumps-specific T lymphocytes seemed to be restricted by epitopes on the HLA-DR molecules. The frequency of mumps antigen-reactive T lymphocytes (ARTL) was found to be low when the response was restricted by DR3-associated elements, and high when it was restricted by DR4-associated elements, compared to the frequency of ARTL when other DR-associated elements restricted the mumps-specific response. For the majority of the individuals tested, the DR-associated hypo- and hyper-responsiveness was found with both the S and the V mumps antigens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2417308     DOI: 10.1111/j.1365-3083.1985.tb01910.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  2 in total

1.  Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3 in clinically healthy individuals.

Authors:  S Hashimoto; C C McCombs; J P Michalski
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

2.  The HLA-DR phenotype modulates the humoral immune response to enterovirus antigens.

Authors:  K Sadeharju; M Knip; M Hiltunen; H K Akerblom; H Hyöty
Journal:  Diabetologia       Date:  2003-07-05       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.